Daré Bioscience
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $-63 | $41 | $22 | $9 |
Gross Profit | -63 | 41 | -2 | -1 |
EBITDA | -5,381 | -4,671 | -7,344 | -6,011 |
EBIT | -5,388 | -4,681 | -7,359 | -6,022 |
Net Income | -5,506 | -4,702 | 12,910 | -6,755 |
Net Change In Cash | -63 | 41 | 22 | 9 |
Free Cash Flow | 4,663 | -5,641 | -6,827 | -6,820 |
Cash | 15,698 | 11,232 | 16,414 | 3,630 |
Basic Shares | 8,497 | 8,534 | 8,476 | 8,376 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9 | $2,807 | $10,000 | $10,000 |
Gross Profit | 9,784 | 2,769 | 10,000 | -26 |
EBITDA | -23,409 | -30,901 | -31,361 | -39,042 |
EBIT | -23,451 | -30,939 | -31,385 | -39,068 |
Net Income | -4,053 | -30,161 | 406,802 | -38,326 |
Net Change In Cash | 9 | 2,807 | 10,000 | 10,000 |
Free Cash Flow | 4,821,201 | -39,486 | -18,151 | -28,778 |
Cash | 15,698 | 10,476 | 34,669 | 51,674 |
Basic Shares | 8,497 | 7,275 | 7,047 | 5,096 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.65 |
2024-09-30 | -$0.55 |
2024-06-30 | -$0.88 |
2024-03-31 | -$0.07 |
